潤啤(00291.HK)升逾4%創超過三個月高 花旗指派特別息有驚喜
華潤啤酒(00291.HK)中午公布去年多賺逾18%,末期息連特別息共派0.649元人民幣。花旗指其派特別息帶來驚喜。
潤啤午後升幅擴大,現升4.68%,報38元,為即市高位並創逾三個月高,10天線升穿100天線呈「黃金交叉」,成交1,854.08萬股,涉資6.85億元。
潤啤去年營業額389.32億元人民幣(下同),按年升10.4%。純利51.53億元,按年升18.6%;每股盈利1.59元。派息共0.649元,包括末期息0.349元及祝賀集團三十周年派發特別息0.3元,上年同期派末期息0.302元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.